Sopharma Trading AD (BUL:SFT)
Bulgaria
· Delayed Price · Currency is BGN 5.60
+0.05 (0.90%)
At close: Apr 16, 2025
Sopharma Trading AD Income Statement
Financials in millions BGN. Fiscal year is January - December.
Millions BGN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 1,933 | 1,673 | 1,479 | 1,336 | 1,156 | Upgrade
|
| Other Revenue | 13.73 | 5.05 | 4.26 | - | - | Upgrade
|
| Revenue | 1,947 | 1,678 | 1,483 | 1,336 | 1,156 | Upgrade
|
| Revenue Growth (YoY) | 15.98% | 13.20% | 11.00% | 15.53% | 22.25% | Upgrade
|
| Cost of Revenue | 1,693 | 1,482 | 1,311 | 1,193 | 1,052 | Upgrade
|
| Gross Profit | 254.07 | 196.02 | 172.13 | 142.34 | 104.06 | Upgrade
|
| Selling, General & Admin | 149.68 | 115.65 | 100.73 | 97.75 | 71.81 | Upgrade
|
| Other Operating Expenses | 6.6 | 3.59 | 1.47 | -0.29 | -5.3 | Upgrade
|
| Operating Expenses | 193.57 | 151.35 | 132.26 | 126.29 | 86.67 | Upgrade
|
| Operating Income | 60.5 | 44.68 | 39.87 | 16.05 | 17.39 | Upgrade
|
| Interest Expense | -15.1 | -8.42 | -5.18 | -5.36 | -4.46 | Upgrade
|
| Interest & Investment Income | - | 0.46 | 0.71 | 2.11 | 1.67 | Upgrade
|
| Earnings From Equity Investments | -0.01 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.13 | -0.11 | -0.16 | -0.19 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.15 | -2.63 | -1.75 | -0.97 | -0.84 | Upgrade
|
| EBT Excluding Unusual Items | 46.55 | 33.96 | 33.55 | 11.66 | 13.57 | Upgrade
|
| Impairment of Goodwill | - | - | -13.33 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.36 | 0.21 | 0.46 | 0.3 | 0.25 | Upgrade
|
| Asset Writedown | - | - | -8.28 | -2.64 | - | Upgrade
|
| Other Unusual Items | - | - | - | 0.12 | 0.1 | Upgrade
|
| Pretax Income | 46.91 | 34.18 | 12.39 | 9.44 | 13.92 | Upgrade
|
| Income Tax Expense | 4.66 | 4.15 | 3.31 | 1.39 | 2.45 | Upgrade
|
| Earnings From Continuing Operations | 42.25 | 30.03 | 9.08 | 8.05 | 11.48 | Upgrade
|
| Minority Interest in Earnings | 0.51 | - | - | - | - | Upgrade
|
| Net Income | 42.76 | 30.03 | 9.08 | 8.05 | 11.48 | Upgrade
|
| Net Income to Common | 42.76 | 30.03 | 9.08 | 8.05 | 11.48 | Upgrade
|
| Net Income Growth | 42.40% | 230.70% | 12.80% | -29.85% | 28.60% | Upgrade
|
| Shares Outstanding (Basic) | 34 | 34 | 34 | 34 | 34 | Upgrade
|
| Shares Outstanding (Diluted) | 34 | 34 | 34 | 34 | 34 | Upgrade
|
| Shares Change (YoY) | -0.20% | - | - | - | - | Upgrade
|
| EPS (Basic) | 1.25 | 0.88 | 0.26 | 0.23 | 0.33 | Upgrade
|
| EPS (Diluted) | 1.25 | 0.88 | 0.26 | 0.23 | 0.33 | Upgrade
|
| EPS Growth | 42.68% | 230.70% | 12.80% | -29.85% | 28.60% | Upgrade
|
| Free Cash Flow | 54.74 | 37.63 | 12.84 | -180.39 | -225.62 | Upgrade
|
| Free Cash Flow Per Share | 1.60 | 1.10 | 0.38 | -5.26 | -6.58 | Upgrade
|
| Gross Margin | 13.05% | 11.68% | 11.61% | 10.66% | 9.00% | Upgrade
|
| Operating Margin | 3.11% | 2.66% | 2.69% | 1.20% | 1.50% | Upgrade
|
| Profit Margin | 2.20% | 1.79% | 0.61% | 0.60% | 0.99% | Upgrade
|
| Free Cash Flow Margin | 2.81% | 2.24% | 0.87% | -13.50% | -19.51% | Upgrade
|
| EBITDA | 97.8 | 73.5 | 67.21 | 28.08 | 26.02 | Upgrade
|
| EBITDA Margin | 5.02% | 4.38% | 4.53% | 2.10% | 2.25% | Upgrade
|
| D&A For EBITDA | 37.3 | 28.82 | 27.34 | 12.03 | 8.63 | Upgrade
|
| EBIT | 60.5 | 44.68 | 39.87 | 16.05 | 17.39 | Upgrade
|
| EBIT Margin | 3.11% | 2.66% | 2.69% | 1.20% | 1.50% | Upgrade
|
| Effective Tax Rate | 9.93% | 12.13% | 26.73% | 14.70% | 17.57% | Upgrade
|
| Advertising Expenses | - | 6.55 | 4.14 | 3.46 | 3.12 | Upgrade
|
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.